Source page on ClearCHS detailing cannabinoid-hyperemesis-syndrome (CHS).

Statistics

  • Affects an estimated 2.75M Americans annually.
  • Emergency department visits doubled in the US and Canada (2017-2021).
  • Frequently misdiagnosed for years due to low clinician awareness.

Etiology & Risks

  • Cause: Chronic overstimulation of gut cannabinoid receptors from heavy, long-term cannabis use.
  • Risk Factors: Daily use for >1 year, onset before age 16, concurrent tobacco/substance use, male sex, and age group 16–34.

The Three Phases

  1. Prodromal: Early morning nausea, mild abdominal discomfort. Can last months/years.
  2. Hyperemetic: Severe, repeated vomiting (up to 5x/hour) and abdominal cramping. Characterized by temporary relief from hot showers or baths.
  3. Recovery: Symptoms resolve within days to weeks after stopping cannabis completely; full recovery may take months.

Other pages